查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球超音波人工智慧市場（按產品、品牌、應用和最終用戶分類）預測（至 2030 年）
市場調查報告書
商品編碼
1836423

全球超音波人工智慧市場（按產品、品牌、應用和最終用戶分類）預測（至 2030 年）

Ultrasound AI Market by Product (AI-enabled System, Solutions ), Brand, Application, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 278 Pages | 訂單完成後即時交付

價格

全球超音波AI 市場規模預計將從 2025 年的 23.5 億美元增至 2030 年的 68.8 億美元，預測期內的複合年成長率為 24.0%。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
單元 10億美元
部分 產品類型、品牌、應用程式、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

市場成長的動力來自於對準確和早期疾病診斷日益成長的需求、圖像分析中使用的機器學習演算法的進步以及人工智慧的整合以簡化工作流程和減少人為錯誤。可攜式和照護現場超音波超音波的日益普及及其在循環系統、婦產科、腫瘤學和急診醫學中的日益廣泛的應用預計將進一步推動市場的發展。

超音波AI市場-IMG1

根據產品類型，人工智慧解決方案/軟體部分在預測期內預計將實現最高的複合年成長率。

根據產品類型，預計預測期內人工智慧解決方案/軟體細分市場將實現最高複合年成長率。此細分市場的高成長率得益於其成本效益和靈活的配置，無需進行大規模硬體升級即可提高診斷準確性和工作流程效率。人工智慧軟體的優勢在於擴充性和持續創新。與需要大量投資週期的硬體不同，軟體可以輕鬆更新演算法、臨床應用和符合法規的功能。雲端基礎平台、遠端醫療和遠距離診斷的日益普及也擴大了人工智慧軟體在醫療保健生態系統中的作用，推動了市場成長。

按品牌分類，EchoPAC 部門在 2024 年佔據了最大的市場佔有率。

按品牌分類，EchoPAC 在超音波人工智慧市場佔有最大佔有率。這得歸功於其作為通用電氣醫療集團 (GE Healthcare) 專為心血管超音波設計的高級分析軟體，已被廣泛採用。 EchoPAC 提供強大的人工智慧驅動工具，用於應變成像、3D/4D 量化和自動測量，顯著提高了診斷準確性和工作流程效率。 EchoPAC 與通用電氣集團 (GE) 的大型運作中超音波系統無縫整合，擁有強大的臨床檢驗，並在全球領先的醫院和心臟中心廣泛使用，使其在人工智慧超音波領域擁有競爭優勢和主導市場佔有率。

按最終用戶分類，預計醫院和手術中心部門將在 2024 年佔據最大佔有率。

2024年，醫院和手術中心憑藉其高病患流量、廣泛的診斷和手術方案以及先進影像技術的廣泛應用，佔據了最大的市場佔有率。這些機構利用人工智慧超音波系統，為心臟病學、婦產科、腫瘤科和急診醫學等各個專業提供精準高效的即時影像診斷。雄厚的財力、熟練的員工隊伍以及人工智慧工具與日常工作流程的整合，進一步提升了營運效率和患者治療效果，鞏固了其相對於研究機構和小型診所等其他終端用戶群體的優勢。

根據地區，預計亞太地區在預測期內將實現最高的市場成長率。

由於醫療基礎設施的快速發展、先進成像技術的普及以及對人工智慧醫療解決方案的投資不斷增加，亞太地區預計將成為超音波人工智慧市場成長最快的地區。人口規模龐大且老化，慢性病和文明病疾病的盛行率不斷上升，以及中國、印度和日本等國家醫療服務可近性不斷提高等因素，正在推動需求成長。此外，政府推動數位健康的舉措、人們對早期疾病檢測意識的不斷增強，以及全球和本地超音波人工智慧製造商的進入，正在進一步加速該地區市場的擴張。

本報告探討並分析了全球超音波人工智慧市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 主要發現

  • 超音波AI市場概況
  • 北美超音波人工智慧市場（按國家和最終用戶分類）（2025 年）
  • 超音波人工智慧市場地理簡介

第5章 市場概況

  • 介紹
  • 市場動態
    • 驅動程式
    • 抑制因素
    • 機會
    • 任務
  • 價值鏈分析
  • 供應鏈分析
    • 知名公司
    • 小型企業
    • 最終用戶
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 專利分析
  • 貿易資料分析
    • 導入數據
    • 匯出數據
  • 大型會議和活動（2025-2026）
  • 未滿足的需求和關鍵問題
  • 生態系分析
  • 2025年美國關稅對超音波AI市場的影響
    • 介紹
    • 主要關稅稅率
    • 價格影響分析
    • 對國家的影響
    • 最終用戶影響
  • 影響客戶業務的趨勢/中斷
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 案例研究分析
  • 監管分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 監管機構、政府機構和其他組織
  • 投資金籌措場景
  • 定價分析
    • 各地區超音波人工智慧平均銷售價格（2022-2024年）
    • 主要企業的平均銷售價格
  • 贖回情景

第6章超音波人工智慧市場（依產品類型）

  • 介紹
  • 人工智慧超音波系統
  • 支援人工智慧的超音波解決方案/軟體

第7章超音波人工智慧市場（按品牌）

  • 介紹
  • EchoPAC
  • Aplio
  • ACUSON
  • Butterfly
  • 其他品牌

超音波AI 市場：按應用

  • 介紹
  • 婦產科
  • 放射學/一般診斷成像
  • 整形外科和肌肉骨骼
  • 心臟病學
  • 泌尿系統
  • 其他用途

第9章超音波人工智慧市場（按最終用戶）

  • 介紹
  • 醫院和外科中心
  • 診斷影像和專科診所
  • 門診護理中心
  • 產科和不孕症診所
  • 其他最終用戶

第 10 章超音波AI 市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
    • 宏觀經濟展望
    • 海灣合作理事會國家
    • 其他中東和非洲地區

第11章 競爭格局

  • 介紹
  • 主要參與企業的策略
  • 收益分析（2021-2024）
  • 市佔率分析（2024年）
  • 公司估值矩陣：超音波人工智慧市場（2024 年）
  • 公司評估矩陣：Start-Ups/中小企業（2024 年）
  • 公司估值及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章：公司簡介

  • 主要企業
    • GE HEALTHCARE
    • PHILIPS HEALTHCARE
    • CANON MEDICAL SYSTEMS CORPORATION
    • SIEMENS HEALTHINEERS AG
    • FUJIFILM CORPORATION
    • HOLOGIC, INC.
    • SAMSUNG ELECTRONICS CO., LTD.
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • SONOSCAPE
    • KONICA MINOLTA, INC
    • BUTTERFLY NETWORK
  • 其他公司
    • EXO IMAGING
    • CHISON MEDICAL TECHNOLOGIES CO., LTD
    • ESASOTE
    • CLARIUS
    • EVIDENT VASCULAR
    • SMARTALPHA
    • TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
    • FRONTWAVE IMAGING
    • DELFT IMAGING
    • EDAN INSTRUMENTS, INC
    • ECHONOUS INC.
    • KOIOS MEDICAL
    • BIOTICS AI
    • TERASON
    • BK MEDICAL
    • MAUI IMAGING
    • SONOLOGIC
    • CONTEXTVISION

第13章 附錄

Product Code: HIT 9486

The global Ultrasound AI market is projected to reach USD 6.88 billion by 2030 from USD 2.35 billion in 2025, growing at a CAGR of 24.0% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct Type, Brand, Application, End User, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

The growth of the market is driven by the increasing demand for accurate and early disease diagnosis, advancements in machine learning algorithms for image analysis, and the integration of AI to enhance workflow efficiency and reduce human error. The rising adoption of portable and point-of-care ultrasound devices, coupled with growing applications in cardiology, obstetrics/gynecology, oncology, and emergency care, is further expected to fuel market expansion.

Ultrasound AI Market - IMG1

By product type, the AI-enabled solutions/software segment is expected to register the highest CAGR during the forecast period.

By product type, the AI-enabled solutions/software segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to the cost-efficiency and flexible provision to enhance diagnostic accuracy and workflow efficiency without the requirement of primary hardware upgrades. AI software benefits from scalability and continuous innovation. Unlike hardware, which requires significant investment cycles, software can be easily updated with new algorithms, clinical applications, and regulatory-compliant features. The growing adoption of cloud-based platforms, telemedicine, and remote diagnostics also expands the role of AI software in healthcare ecosystems, fueling market growth.

By brand, the EchoPAC segment accounted for the largest share of the market in 2024.

By brand, the EchoPAC segment accounts for the highest market share in the ultrasound AI market by brand because it is GE Healthcare's widely adopted advanced analysis software, specifically designed for cardiovascular ultrasound. It offers robust AI-driven tools for strain imaging, 3D/4D quantification, and automated measurements, which significantly improve diagnostic accuracy and workflow efficiency. Its seamless integration with GE's large installed base of ultrasound systems, strong clinical validation, and broad use across leading hospitals and cardiology centers worldwide give EchoPAC a competitive edge, enabling it to dominate market share in the AI-enabled ultrasound segment.

By end user, the hospitals & surgical centers segment accounted for the largest share of the market in 2024.

In 20254, the hospitals & surgical centers segment accounted for the largest share of the market due to its high patient inflow, broad range of diagnostic and interventional procedures, and extensive adoption of advanced imaging technologies. These facilities leverage AI-enabled ultrasound systems for accurate, efficient, and real-time imaging across various specialties, including cardiology, obstetrics/gynecology, oncology, and emergency care. The strong financial capacity, skilled workforce, and integration of AI tools into routine workflows further enhance operational efficiency and patient outcomes, solidifying their dominant position over other end-user segments such as research institutes or smaller clinics.

By region, the Asia Pacific is expected to register the highest growth rate in the market during the forecast period.

The Asia Pacific region is expected to witness the highest growth rate in the Ultrasound AI market due to rapid advancements in healthcare infrastructure, increasing adoption of advanced imaging technologies, and rising investments in AI-driven medical solutions. Factors such as a large and aging population, growing prevalence of chronic and lifestyle-related diseases, and expanding access to healthcare services in countries like China, India, and Japan are driving demand. Additionally, government initiatives promoting digital health, increasing awareness of early disease detection, and the entry of global and local Ultrasound AI manufacturers are further accelerating market expansion in the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level Executives (55%), Directors (27%), and Others (18%)

By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%)

The prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc. (US), Samsung Electronics Co., Ltd (South Korea), Butterfly Network (US), Chison Medical Technologies Co., Ltd (China), and Clarius (Canada), among others.

Research Coverage

The ultrasound AI market is segmented by product type, brand, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Ultrasound AI market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions.

Key Benefits of Buying the Report

The report is valuable for new entrants in the Ultrasound AI market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report offers insights into both key and smaller players in the market, which can help in creating a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis.

The report provides insights into the following points:

  • Key drivers (rising prevalence of chronic diseases, integration with portable and point-of-care devices, advancements in AI algorithms, rising healthcare expenditure and supportive government policies, rising collaborations between med-tech companies and ai startups), restraints (high maintenance and upgrade costs, regulatory hurdles and approval delays), opportunities (expansion of portable ultrasound, integration with electronic health records), and challenges (resistance to adoption among clinicians, data privacy and security concerns) fueling the market growth of ultrasound ai market.
  • Product Development/Innovation: Emerging technologies in space, R&D, recent product & service launches in the Ultrasound AI market.
  • Market Growth: In-depth insights into remunerative markets report analyze the Ultrasound AI market across varied geographies.
  • Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the Ultrasound AI market
  • Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), and FUJIFILM Corporation (Japan), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 ULTRASOUND AI MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION APPROACH
    • 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
    • 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
  • 2.3 MARKET FORECASTING APPROACH
  • 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ULTRASOUND AI MARKET OVERVIEW
  • 4.2 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY AND END USER, 2025
  • 4.3 GEOGRAPHIC SNAPSHOT OF ULTRASOUND AI MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Integration with portable and point-of-care devices
      • 5.2.1.2 Advancements in AI algorithms
      • 5.2.1.3 Rising healthcare expenditure and supportive government policies
      • 5.2.1.4 Rising collaboration between MedTech companies and AI startups
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High maintenance and upgrade costs
      • 5.2.2.2 Regulatory hurdles and approval delays
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expansion of portable ultrasound with AI integration
      • 5.2.3.2 AI-driven fetal health monitoring
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Resistance to adoption among clinicians
      • 5.2.4.2 Data privacy and security concerns
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • 5.4.1 PROMINENT COMPANIES
    • 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.4.3 END USERS
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF SUBSTITUTES
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.6.2 BUYING CRITERIA
  • 5.7 PATENT ANALYSIS
  • 5.8 TRADE DATA ANALYSIS
    • 5.8.1 IMPORT DATA
    • 5.8.2 EXPORT DATA
  • 5.9 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.10 UNMET NEEDS AND KEY PAIN POINTS
  • 5.11 ECOSYSTEM ANALYSIS
  • 5.12 IMPACT OF 2025 US TARIFF-ULTRASOUND AI MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRY/REGION
      • 5.12.4.1 US
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END USERS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.14 TECHNOLOGY ANALYSIS
    • 5.14.1 KEY TECHNOLOGIES
      • 5.14.1.1 3D/4D imaging with AI enhancement
      • 5.14.1.2 Cloud computing & data analytics
    • 5.14.2 COMPLEMENTARY TECHNOLOGIES
      • 5.14.2.1 Wearable devices & IoMT
    • 5.14.3 ADJACENT TECHNOLOGIES
      • 5.14.3.1 Positron emission tomography (PET) and molecular imaging
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 IMV OFFERS EFFICIENT POWER FOR HANDHELD ULTRASOUND UNITS
    • 5.15.2 ADVANCEMENTS IN USE OF ULTRASOUND AI PRE-HOSPITAL EMERGENCIES AND DISASTER RESPONSE SETTINGS
    • 5.15.3 USE OF HANDHELD ULTRASOUND AI IN RURAL HOSPITAL IN GUATEMALA
  • 5.16 REGULATORY ANALYSIS
    • 5.16.1 NORTH AMERICA
      • 5.16.1.1 US
      • 5.16.1.2 Canada
    • 5.16.2 EUROPE
    • 5.16.3 ASIA PACIFIC
      • 5.16.3.1 Japan
      • 5.16.3.2 China
      • 5.16.3.3 India
    • 5.16.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 PRICING ANALYSIS
    • 5.18.1 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022-2024 (USD)
    • 5.18.2 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD)
  • 5.19 REIMBURSEMENT SCENARIO

6 ULTRASOUND AI MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
  • 6.2 AI-ENABLED ULTRASOUND SYSTEMS
    • 6.2.1 HANDHELD ULTRASOUND
      • 6.2.1.1 Rapid diagnostic capabilities to drive market
    • 6.2.2 CART-BASED ULTRASOUND
      • 6.2.2.1 Enhanced clinical imaging to fuel growth
    • 6.2.3 POINT OF CARE ULTRASOUND
      • 6.2.3.1 Support for diverse clinical applications to lead market growth
  • 6.3 AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE
    • 6.3.1 IMAGE EVALUATION SOFTWARE
      • 6.3.1.1 Enhanced clinical precision with ultrasound AI image analysis
    • 6.3.2 RADIOLOGY SOFTWARE
      • 6.3.2.1 Smart ultrasound diagnostics to boost growth
    • 6.3.3 WORKFLOW PLANNING & SUPPORT SOFTWARE
      • 6.3.3.1 Optimization of ultrasound workflow for better patient outcomes - key driver
    • 6.3.4 OTHER AI SOLUTIONS

7 ULTRASOUND AI MARKET, BY BRAND

  • 7.1 INTRODUCTION
  • 7.2 ECHOPAC
    • 7.2.1 IMPROVED PATIENT EXPERIENCE WITH ECHOPAC SOFTWARE IN HOSPITALS AND SURGICAL CENTERS
  • 7.3 APLIO
    • 7.3.1 IMAGE OPTIMIZATION AND REAL-TIME DECISION SUPPORT TO FUEL MARKET GROWTH
  • 7.4 ACUSON
    • 7.4.1 ADVANCED DIAGNOSTICS WITH AI-BASED ACUSON SYSTEM
  • 7.5 BUTTERFLY
    • 7.5.1 INTEGRATION OF AI IN SMARTPHONES & TABLETS TO DRIVE MARKET GROWTH
  • 7.6 OTHER BRANDS

8 ULTRASOUND AI MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 OBSTETRICS/GYNECOLOGY
    • 8.2.1 HIGH LEVEL OF INNOVATION TO DRIVE MARKET
  • 8.3 RADIOLOGY/GENERAL IMAGING
    • 8.3.1 TRANSFORMING DIAGNOSTIC WORKFLOWS WITH INTEGRATED AI MODEL
  • 8.4 ORTHOPEDIC & MUSCULOSKELETAL
    • 8.4.1 RISING PREVALENCE OF OSTEOARTHRITIS TO LEAD MARKET GROWTH
  • 8.5 CARDIOLOGY
    • 8.5.1 ACCELERATED CARDIAC ASSESSMENTS WITH AI BORDER MAPPING TO DRIVE SEGMENT
  • 8.6 UROLOGICAL
    • 8.6.1 WIDE USE IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO BOOST MARKET
  • 8.7 OTHER APPLICATIONS

9 ULTRASOUND AI MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & SURGICAL CENTERS
    • 9.2.1 HIGH ADOPTION OF AI-INTEGRATED ULTRASOUND TO BOOST MARKET
  • 9.3 IMAGING & SPECIALTY CLINICS
    • 9.3.1 EARLY DISEASE DETECTION AND PERSONALIZED TREATMENT LEAD TO MARKET GROWTH
  • 9.4 AMBULATORY CARE CENTERS
    • 9.4.1 SUPPORTIVE EARLY DETECTION & PREVENTIVE CARE TO PROPEL MARKET GROWTH
  • 9.5 MATERNITY & FERTILITY CLINICS
    • 9.5.1 AI INTEGRATION SYSTEMS LEAD TO PRECISE AND EFFICIENT TREATMENT
  • 9.6 OTHER END USERS

10 ULTRASOUND AI MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Presence of advanced healthcare infrastructure to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Investments in healthcare AI to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Favorable healthcare policies and regulatory landscape to drive market
    • 10.3.3 UK
      • 10.3.3.1 Funding by government bodies to drive market
    • 10.3.4 FRANCE
      • 10.3.4.1 Increasing demand for routine health check-ups, prenatal care, and diagnostic procedures to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Increased availability of reimbursement coverage to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing adoption of point-of-care ultrasound AI to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Emphasis on modernization and expansion of healthcare infrastructure to drive market
    • 10.4.3 JAPAN
      • 10.4.3.1 Rise in breast cancer diagnosis using ultrasound AI to boost market
    • 10.4.4 INDIA
      • 10.4.4.1 Investments and funding activities to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing investments in healthcare infrastructure to drive market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Rising investments in AI & conference events to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing adoption of healthcare insurance to drive market
    • 10.5.3 MEXICO
      • 10.5.3.1 Investment in ultrasound AI devices to drive market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Government initiatives aimed at digital health and telemedicine to drive market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND AI MARKET
  • 11.3 REVENUE ANALYSIS, 2021-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX: ULTRASOUND AI MARKET, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Application footprint
      • 11.5.5.5 End user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key startups/SMEs
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 GE HEALTHCARE
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches & approvals
        • 12.1.1.3.2 Deals
        • 12.1.1.3.3 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 PHILIPS HEALTHCARE
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches & approvals
        • 12.1.2.3.2 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 CANON MEDICAL SYSTEMS CORPORATION
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 SIEMENS HEALTHINEERS AG
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
        • 12.1.4.3.2 Deals
        • 12.1.4.3.3 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 FUJIFILM CORPORATION
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
        • 12.1.5.3.3 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 HOLOGIC, INC.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
        • 12.1.6.2.1 Deals
        • 12.1.6.2.2 Expansions
    • 12.1.7 SAMSUNG ELECTRONICS CO., LTD.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
        • 12.1.7.3.2 Deals
        • 12.1.7.3.3 Other developments
    • 12.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product launches
        • 12.1.8.3.2 Deals
        • 12.1.8.3.3 Other developments
    • 12.1.9 SONOSCAPE
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 KONICA MINOLTA, INC
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches & approvals
        • 12.1.10.3.2 Deals
    • 12.1.11 BUTTERFLY NETWORK
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product launches
        • 12.1.11.3.2 Deals
        • 12.1.11.3.3 Expansions
  • 12.2 OTHER PLAYERS
    • 12.2.1 EXO IMAGING
    • 12.2.2 CHISON MEDICAL TECHNOLOGIES CO., LTD
    • 12.2.3 ESASOTE
    • 12.2.4 CLARIUS
    • 12.2.5 EVIDENT VASCULAR
    • 12.2.6 SMARTALPHA
    • 12.2.7 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
    • 12.2.8 FRONTWAVE IMAGING
    • 12.2.9 DELFT IMAGING
    • 12.2.10 EDAN INSTRUMENTS, INC
    • 12.2.11 ECHONOUS INC.
    • 12.2.12 KOIOS MEDICAL
    • 12.2.13 BIOTICS AI
    • 12.2.14 TERASON
    • 12.2.15 BK MEDICAL
    • 12.2.16 MAUI IMAGING
    • 12.2.17 SONOLOGIC
    • 12.2.18 CONTEXTVISION

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ULTRASOUND AI MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 KEY TECHNOLOGICAL ADVANCEMENTS IN POCUS
  • TABLE 3 ULTRASOUND AI MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 5 KEY BUYING CRITERIA, BY END USER
  • TABLE 6 ULTRASOUND AI MARKET: KEY PATENTS, 2022-2024
  • TABLE 7 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 8 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 9 ULTRASOUND AI MARKET: KEY CONFERENCES & EVENTS, 2025-2026
  • TABLE 10 ULTRASOUND AI MARKET: CURRENT UNMET NEEDS
  • TABLE 11 ULTRASOUND AI MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022-2024 (USD THOUSAND)
  • TABLE 24 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD)
  • TABLE 25 US: MAJOR CPT CODES FOR ULTRASOUND, 2025
  • TABLE 26 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 27 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 28 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 HANDHELD: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 CART-BASED: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 POINT OF CARE: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 33 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 IMAGE EVALUATION SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 RADIOLOGY SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 WORKFLOW PLANNING & SUPPORT SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 OTHER AI SOLUTIONS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 39 ECHOPAC: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 APLIO: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 ACUSON: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 BUTTERFLY: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 OTHER BRANDS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 45 OBSTETRICS/GYNECOLOGY: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 COMPARISON OF HUMAN RADIOLOGISTS VS. AI MODELS
  • TABLE 47 RADIOLOGY/GENERAL IMAGING: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 ORTHOPEDIC & MUSCULOSKELETAL: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 CARDIOLOGY: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 UROLOGICAL: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 OTHER APPLICATIONS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 53 HOSPITALS & SURGICAL CENTERS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 IMAGING & SPECIALTY CLINICS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 AMBULATORY CARE CENTERS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 MATERNITY & FERTILITY CLINICS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 OTHER END USERS: ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 ULTRASOUND AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 NUMBER OF UNITS SOLD BY BUTTERFLY NETWORK
  • TABLE 60 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 61 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 68 US: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 US: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 70 US: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 71 CANADA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 CANADA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 73 CANADA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 75 EUROPE: ULTRASOUND AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 78 EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 EUROPE: ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 80 EUROPE: ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 81 EUROPE: ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 82 GERMANY: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 GERMANY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 84 GERMANY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 85 UK: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 UK: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 87 UK: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 FRANCE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 FRANCE : AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 90 FRANCE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 ITALY: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 ITALY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 93 ITALY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 SPAIN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 SPAIN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 96 SPAIN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 REST OF EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 REST OF EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 99 REST OF EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: ULTRASOUND AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • TABLE 102 ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 104 ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 108 CHINA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 CHINA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 110 CHINA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 JAPAN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 JAPAN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 113 JAPAN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 INDIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 INDIA: AI-ENABLED ULTRASOUND SYSTEMS, MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 116 INDIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 AUSTRALIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 AUSTRALIA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 119 AUSTRALIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 SOUTH KOREA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 SOUTH KOREA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 122 SOUTH KOREA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 125 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 126 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 127 LATIN AMERICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 130 LATIN AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 LATIN AMERICA: ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 132 LATIN AMERICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 133 LATIN AMERICA: ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 134 BRAZIL: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 BRAZIL: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 136 BRAZIL: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 MEXICO: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 MEXICO: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 139 MEXICO: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 142 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 144 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 153 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 REST OF MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 MILLION)
  • TABLE 156 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ULTRASOUND AI MARKET
  • TABLE 158 ULTRASOUND AI MARKET: DEGREE OF COMPETITION
  • TABLE 159 ULTRASOUND MARKET: REGION FOOTPRINT
  • TABLE 160 ULTRASOUND AI MARKET: PRODUCT FOOTPRINT
  • TABLE 161 ULTRASOUND AI MARKET: APPLICATION FOOTPRINT
  • TABLE 162 ULTRASOUND AI MARKET: END USER FOOTPRINT
  • TABLE 163 ULTRASOUND AI MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 164 ULTRASOUND AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 165 ULTRASOUND AI MARKET: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 166 ULTRASOUND AI MARKET: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 167 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 168 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 169 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 170 GE HEALTHCARE: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 171 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021- AUGUST 2025
  • TABLE 172 PHILIPS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 173 PHILIPS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 174 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- AUGUST 2025
  • TABLE 175 PHILIPS HEALTHCARE: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 176 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 177 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 178 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 179 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 180 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 181 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 182 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
  • TABLE 183 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 184 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 185 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 186 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 187 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 188 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 189 FUJIFILM CORPORATION: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 190 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 191 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 192 HOLOGIC, INC.: PRODUCTS OFFERED
  • TABLE 193 HOLOGIC, INC.: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 194 HOLOGIC, INC.: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 196 SAMSUNG ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 197 SAMSUNG ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 198 SAMSUNG ELECTRONICS CO., LTD.: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 199 SAMSUNG ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2025
  • TABLE 200 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY OVERVIEW
  • TABLE 201 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCTS OFFERED
  • TABLE 202 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 203 MINDRAY MEDICAL INTERNATIONAL LIMITED: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 204 MINDRAY MEDICAL INTERNATIONAL LIMITED: OTHER DEVELOPMENTS, JANUARY 2021- AUGUST 2025
  • TABLE 205 SONOSCAPE: COMPANY OVERVIEW
  • TABLE 206 SONOSCAPE: PRODUCTS OFFERED
  • TABLE 207 KONICA MINOLTA, INC.: COMPANY OVERVIEW
  • TABLE 208 KONICA MINOLTA, INC: PRODUCTS OFFERED
  • TABLE 209 KONICA MINOLTA, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- AUGUST 2025
  • TABLE 210 KONICA MINOLTA, INC: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 211 BUTTERFLY NETWORK: COMPANY OVERVIEW
  • TABLE 212 BUTTERFLY NETWORK: PRODUCTS OFFERED
  • TABLE 213 BUTTERFLY NETWORK: PRODUCT LAUNCHES, JANUARY 2021- AUGUST 2025
  • TABLE 214 BUTTERFLY NETWORK: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 215 BUTTERFLY NETWORK: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 216 EXO IMAGING: COMPANY OVERVIEW
  • TABLE 217 CHISON MEDICAL TECHNOLOGIES CO., LTD: COMPANY OVERVIEW
  • TABLE 218 ESASOTE: COMPANY OVERVIEW
  • TABLE 219 CLARIUS: COMPANY OVERVIEW
  • TABLE 220 EVIDENT VASCULAR: COMPANY OVERVIEW
  • TABLE 221 SMARTALPHA: COMPANY OVERVIEW
  • TABLE 222 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING: COMPANY OVERVIEW
  • TABLE 223 FRONTWAVE IMAGING: COMPANY OVERVIEW
  • TABLE 224 DELFT IMAGING: COMPANY OVERVIEW
  • TABLE 225 EDAN INSTRUMENTS, INC: COMPANY OVERVIEW
  • TABLE 226 ECHONOUS INC.: COMPANY OVERVIEW
  • TABLE 227 KOIOS MEDICAL: COMPANY OVERVIEW
  • TABLE 228 BIOTICS AI: COMPANY OVERVIEW
  • TABLE 229 TERASON: COMPANY OVERVIEW
  • TABLE 230 BK MEDICAL: COMPANY OVERVIEW
  • TABLE 231 MAUI IMAGING: COMPANY OVERVIEW
  • TABLE 232 SONOLOGIC: COMPANY OVERVIEW
  • TABLE 233 CONTEXTVISION: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 KEY SECONDARY SOURCES
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 ULTRASOUND AI MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 8 ULTRASOUND AI MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 GLOBAL MARKET GROWTH PROJECTIONS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 ULTRASOUND AI MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 ULTRASOUND AI MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 INTEGRATION WITH OTHER IMAGING MODALITIES TO DRIVE MARKET
  • FIGURE 16 HOSPITALS & SURGICAL CENTERS TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 17 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 18 ULTRASOUND AI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 ULTRASOUND AI MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 ULTRASOUND AI MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 ULTRASOUND AI MARKET: PORTER'S FIVE FORCES
  • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 23 KEY BUYING CRITERIA, BY END USER
  • FIGURE 24 PATENT ANALYSIS FOR ULTRASOUND AI MARKET (JANUARY 2014-AUGUST
  • FIGURE 25 ULTRASOUND AI MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 INVESTMENT & FUNDING SCENARIO, 2019-2023
  • FIGURE 28 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 29 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 30 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022-2024 (USD)
  • FIGURE 31 NORTH AMERICA: ULTRASOUND AI MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: ULTRASOUND AI MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN ULTRASOUND AI MARKET, 2021-2024 (USD BILLION)
  • FIGURE 34 ULTRASOUND AI MARKET SHARE ANALYSIS (2024)
  • FIGURE 35 RANKING OF KEY PLAYERS IN ULTRASOUND AI MARKET, 2024
  • FIGURE 36 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 37 ULTRASOUND AI MARKET: COMPANY FOOTPRINT
  • FIGURE 38 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 ULTRASOUND AI MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 42 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 43 PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 44 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • FIGURE 46 FUJIFILM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 47 HOLOGIC, INC.: COMPANY SNAPSHOT
  • FIGURE 48 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 49 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
  • FIGURE 50 KONICA MINOLTA, INC: COMPANY SNAPSHOT